The University of Utah UCV and Faculty Profile systems are under development and may not display the full or correct information for our faculty. Any incorrect or incomplete information shown here while we are working on the system should not be seen as a reflection of the University of Utah faculty members.
-
Professor (Lecturer), College Of Law
Publications
- Kenneth Chahine (date unknown). Amgen battles for EPO in Congress. Nature Biotechnology, Nov;16:999-1000 (1998).
Accepted, .
- Kenneth Chahine (date unknown). The importance of "legalese" in biotechnology patents. Nature Biotechnology, Oct;16: 971-2(1998).
Accepted, .
- Kenneth Chahine (date unknown). Hatch-Waxman changes debated. Nature Biotechnology, Jul;18: 710-1(2000).
Accepted, .
- Kenneth Chahine (date unknown). Building the proper foundation for genomic based patents, Nature Biotechnology, 16: 683-684 (1998).
Accepted, .
- Kenneth Chahine (date unknown). Industry opposes genomic legislation. Nature Biotechnology, May;20: 419 (2002).
Accepted, .
- Kenneth Chahine (date unknown). Amgen preserves erythropoietin monopoly for now. Nature Biotechnology, Mar;19: 188 (2001).
Accepted, .
- Kenneth Chahine (date unknown). All clear for HIV-targeting ribozyme in phase II. Nature Biotechnology, Feb;16:123(1998).
Accepted, .
- Kenneth Chahine (date unknown). Cancer prognostic approved. Nature Biotechnology, Feb;16:121(1998).
Accepted, .
- Kenneth Chahine (date unknown). Patent office resurrects EST debate, Nature Biotechnology, 16: 711 (1998).
Accepted, .
- Kenneth Chahine (date unknown). Genentech sues to protect clot buster market share, Nature Biotechnology, 16: 410 (1998).
Accepted, .
- Kenneth Chahine (date unknown). Elanex battles for piece of erythropoietin market, Nature Biotechnology, 16: 16 (1998).
Accepted, .
- Kenneth Chahine (date unknown). US courts disagree on generic exclusivity, Nature Biotechnology, 16: 132 (1998).
Accepted, .
- Kenneth Chahine (date unknown). Going beyond the native: Protecting DNA and protein patents, Nature Biotechnology, 15: 183-185 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Enabling DNA and Protein Claims: Why Claiming Biological Equivalents Encourages Innovation, American Intellectual Property Law Association Quarterly Journal, 25(3): 333 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Wrangling over the rights to BRAC1, Nature Biotechnology, 15: 936 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Eli Lilly Wins on Appeal, Nature Biotechnology, 15: 823 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Patenting Genes: Just when you thought it was safe, Nature Biotechnology, 15: 586-587 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Amgen Protects its Billion Dollar Protein, Nature Biotechnology, 15: 496-497 (1997).
Accepted, .
- Kenneth Chahine (date unknown). University of Colorado wins inventorship dispute with American Cyanamid, Nature Biotechnology, 15: 831 (1997).
Accepted, .
- Kenneth Chahine (date unknown). An Industry in Focus: Utah's Biotechnology Boom, Utah Business, October: 27-31 (1997).
Accepted, .
- Kenneth Chahine (date unknown). Electrical Activity Suppresses Nicotinic Acetylcholine Receptor Gamma Subunit Promoter Activity. Developmental Biology, 168: 416-428 (1995).
Accepted, .
- Kenneth Chahine (date unknown). Calcium Regulates the Expression of the Nicotinic Acetylcholine Receptor Subunit RNAs, Journal of Biological Chemistry, 269: 19447-19456, (1994).
Accepted, .
- Kenneth Chahine (date unknown). Coupling Muscle Electrical Activity to Nicotinic Acetylcholine Receptor Gene Expression Via a Cyclic AMP-Dependent Second Messenger System, Journal of Biological Chemistry, 268, 2893-2898, (1993).
Accepted, .
- Kenneth Chahine (date unknown). Molecular and electrophysiological characterization of the allelic variant of the rat alpha-6 GABA-A receptor subunit, Molecular Brain Research, 16, 173-178, (1992).
Accepted, .
- Kenneth Chahine (date unknown). A 102 Base Pair Sequence Confers Electrical Regulation on the Nicotinic Acetylcholine Receptor (nAChR) Delta-Subunit, Development, 12 , 123-128, (1992).
Accepted, .